Skip to content
healthcare.dev
Get a free key

Sugar Control

NDC 85631-008, MORUS ALBA LEAF, tablet, from Bispit Canada Ltd..

Product NDC
85631-008
Status
Listed
Labeler
Bispit Canada Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85631-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASTRAGALUS CRASSICARPUS WHOLE132 mg/.6g
  • PUERARIN84.6 mg/.6g
  • YEAST, UNSPECIFIED31.8 mg/.6g
  • MORUS ALBA LEAF232.5 mg/.6g
  • MOMORDICA CHARANTIA WHOLE68.7 mg/.6g

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
85631-008-018563100080190 CAPSULE in 1 BOTTLE (85631-008-01) / .6 g in 1 CAPSULE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85631-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85631-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85631-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.